![](https://endpts.com/wp-content/uploads/2023/03/Bill-Meury-Karuna-Therapeutics.jpg)
Bill Meury, Karuna Therapeutics CEO
Karuna to raise $400M in market a day after positive readout of schizophrenia drug
Karuna Therapeutics plans to raise $400 million in a stock sale, a day after releasing more positive data for one of its schizophrenia drugs, and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.